Immix Biopharma, Inc. IMMX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s prepaid & other current?
- Immix Biopharma, Inc. (IMMX) reported prepaid & other current of $1.7M in Q1 2026.
- How has Immix Biopharma, Inc.'s prepaid & other current changed year-over-year?
- Immix Biopharma, Inc.'s prepaid & other current increased by 97.6% year-over-year, from $858.14K to $1.7M.
- What is the long-term trend for Immix Biopharma, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s prepaid & other current has grown at a 55.2% compound annual growth rate (CAGR), from $519.12K to $3.01M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.